Esketamine (ESK) nasal spray monotherapy was found to be efficacious over placebo in adults with treatment-resistant depression, according to recent randomized, double-blind study results reported in a...
Rates of clinically diagnosed depression and anxiety without depression increased between 2017 and 2021, especially during the COVID-19 pandemic, according to recent cohort study results published in JAMA...
Chronic pain in youth was associated with an increased risk of anxiety and depression, particularly when compared to symptoms of youth without chronic pain. Results from the systematic review and...
Increases in depressive symptoms during adolescence can persist into young adulthood, according to recent cohort study results published in JAMA Network Open.
More than one-third of young adults in the United States were found to have had anxiety or depression during the COVID-19 pandemic in a cross-sectional study recently published in JAMA Network Open. ...
Many adults with gastroesophageal reflux disease (GERD) experience symptoms of anxiety and depression, suggesting a bidirectional causal relationship, according to a recent study published in the American...
Adults with moderate to severe depression were found to have a higher all-cause risk of ischemic heart and cardiovascular disease (CVD) mortality than adults without depression, according to a prospective...
Patients with remitted major depressive disorder (MDD) appear to have more difficulty with the cognitive control of negative than positive information, according to study results published in the Journal of...
Depression in fathers was associated with a 42% increased risk of depression in their children, according to results from a systematic review and meta-analysis published online in JAMA Network Open. ...
